$IMMB MUST READ BOLD in PR >>

Immunotech Laboratories (IMMB) Patented "IPF" Technology A Serious Contender In The Race For HIV & Cancer Cures

PASADENA, Calif., Feb. 4, 2013 /PRNewswire/ -- CSNNewswire/Immunotech Laboratories, Inc. (PINKSHEETS:IMMB)

Company Director Mr. Bo. Linton of Immunotech Laboratories, Inc, a  Pasadena California based publicly traded company with patented "IPF" Technology  today stated Immunotech's technology  is now considered a major contender in the race for HIV & Cancer cures.  Recent information provided by the company for clinical testing results in both the HIV and Cancer sectors for terminal (Salvage) patients showed the use of the company's patented "IPF" vaccine treatments significantly reduced the number of infected cells while leaving the non infected cells in tact, and almost immediately started the regeneration of the body's natural immune system.

Mr. Linton further commented the company recently received an initial inquiry for a significant order of the company's patented HIV vaccine by an International associate for use as an "Experimental Drug".  If confirmed the initial order would be in excess of several Million Dollars. This would expand the company's operations from Research & Development to a Bio-Pharma manufacturing company. In Africa, where approved experimental treatments are permitted, there are approximately 30 Million HIV/AIDS patients alone.